BiotechTube

Pramipexole ER + Escitalopram

Phase 2Recruiting
0 views this week 0 watching⚡ Active🏛️Featured in Big Pharma Pipeline
Interest: 42/100
42
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Major Depressive Disorder

Conditions

Major Depressive Disorder, Mild Neurocognitive Disorder, HIV

Trial Timeline

Feb 15, 2026 → Dec 2, 2026

NCT ID
NCT06705478

About Pramipexole ER + Escitalopram

Pramipexole ER + Escitalopram is a phase 2 stage product being developed by Cipla for Major Depressive Disorder. The current trial status is recruiting. This product is registered under clinical trial identifier NCT06705478. Target conditions include Major Depressive Disorder, Mild Neurocognitive Disorder, HIV.

What happened to similar drugs?

20 of 20 similar drugs in Major Depressive Disorder were approved

Approved (20) Terminated (0) Active (0)
✅Mirtazapine TabletsSun PharmaceuticalApproved
✅DuloxetineEli LillyApproved
✅duloxetineEli LillyApproved
✅DuloxetineEli LillyApproved
✅duloxetine hydrochlorideEli LillyApproved
✅DuloxetineEli LillyApproved
✅DuloxetineEli LillyApproved

Hype Score Breakdown

Clinical
12
Activity
15
Company
15
Novelty
0
Community
0

Clinical Trials (1)

NCT IDPhaseStatus
NCT06705478Phase 2Recruiting

Competing Products

20 competing products in Major Depressive Disorder

See all competitors
ProductCompanyStageHype Score
Duloxetine HydrochlorideEli LillyPre-clinical
26
LY2216684Eli LillyPhase 1
29
LY2216684Eli LillyPhase 1
29
DuloxetineEli LillyPhase 3
40
LY2216684 + DigoxinEli LillyPhase 1
29
Duloxetine + ParoxetineEli LillyPhase 3
40
Duloxetine + placeboEli LillyPhase 3
40
LY2216684 + Placebo + EscitalopramEli LillyPhase 2
35
FK949EAstellas PharmaPhase 1
29
quetiapine extended release (XR) + PlaceboAstellas PharmaPhase 2
35
FK949EAstellas PharmaPhase 1
29
FK949EAstellas PharmaPhase 1
29
FK949EAstellas PharmaPhase 1
29
Mirtazapine TabletsSun PharmaceuticalApproved
43
ONO-2333Ms Experimental 2 + Placebo + ONO-2333Ms Experimental 1Ono PharmaceuticalPhase 2
35
ONO-1110 + PlaceboOno PharmaceuticalPhase 2
39
LY2216684 + SertralineEli LillyPhase 1
29
LY2216684 + Placebo + LorazepamEli LillyPhase 1
29
LY2216684 + SSRIEli LillyPhase 3
40
DuloxetineEli LillyApproved
43